Automated image analyses of glomerular hypertrophy in a mouse model of diabetic nephropathy
Kidney360 1(6): 469-479, 2020
Whole-brain 3D imaging for quantification of drug targets and treatment effects in mouse models of neurodegenerative diseases
Neural Regeneration Research 15(12):2255-2257, 2020
Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis
Nature Metabolism 2(5):413–431, 2020
Activation of adenosine monophosphate-activated protein kinase reduces the onset of diet-induced hepatocellular carcinoma in mice
Hepatology Communications 4(7):1056-1072, 2020
Rodent models of diabetic kidney disease: human translatability and preclinical validity
Drug Discovery Today 26(1):200-217, 2021
Incretin combination therapy for the treatment of non-alcoholic steatohepatitis
Diabetes, Obesity and Metabolism 22(8):1328-1338, 2020
Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis
Scientific Reports 10(1):1148, 2020
Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH
BMC Gastroenterology 19(1):228, 2019